Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | S100B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | MYLK | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | FERMT2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | DVL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | IKBIP | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
mRNA | SEC22C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | MPO | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | SERPINB9 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | AC027682.1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | TPX2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |